P2Y12 inhibitors

187 Novel thienopyridines are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin
Naif Binsaleh, Catherine A. Wigley, Kathryn A. Whitehead, Daniel Moreno-Martinez, Sarah Daniels, Sarah Jones, Michelle van Rensburg, Lisa Pilkington, David Barker, Nina Dempsey-Hibbert

Heart Jun 2017, 103 (Suppl 5) A128; DOI: 10.1136/heartjnl-2017-311726.185
111 The Degree and Time Course of Platelet Inhibition Following the Administration of Oral Antiplatelet Agents in Patients Presenting with ST Elevation MI (STEMI)
Nazish Khan, Amoah Vincent, Andrew Smallwood, Ben Wrigley, Joe Martins, Saib Khogali, Munir Shahzad, Nevill Alan, James Cotton

Heart Jun 2016, 102 (Suppl 6) A78-A79; DOI: 10.1136/heartjnl-2016-309890.111
203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia
Mark Thomas, Ramzi Ajjan, Fladia Phoenix, Samuel Outteridge, David Dockrell, Ian Sabroe, Robert Storey

Heart Jun 2015, 101 (Suppl 4) A112; DOI: 10.1136/heartjnl-2015-308066.203
11 Optimal P2Y12 Blockade in Oral Dual Antiplatelet Therapy for Women with Coronary Heart Disease – A Systematic Review and Meta-Analysis
Oliver Brown, Jennifer Rossington, Angela Hoye

Heart Jun 2015, 101 (Suppl 4) A7; DOI: 10.1136/heartjnl-2015-308066.11
215 Ticagrelor Inhibits Release of Pro-inflammatory Cytokines TNF and IL-6 during Human Endotoxaemia
Mark Thomas, Heather Judge, David Dockrell, Ian Sabroe, Robert Storey

Heart Jun 2014, 100 (Suppl 3) A117-A118; DOI: 10.1136/heartjnl-2014-306118.215

Log in using your username and password

Main menu

Log in using your username and password

You are here

P2Y12 inhibitors